$SOBI.ST

2 stories mentioning SOBI.STUpdated 26m ago

Every FINWIRES story that references SOBI.ST, newest first.

Pareto Securities Downgrades Swedish Orphan Biovitrum to Hold

Pareto Securities on Monday downgraded biopharmaceutical company Swedish Orphan Biovitrum (SOBI.ST) to hold from buy, while keeping the price target at 470 kronor.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SOBI.ST

Research54d ago

HC Wainwright Kicks Off Swedish Orphan Biovitrum Coverage at Buy

HC Wainwright & Co. on Wednesday started its coverage of Swedish Orphan Biovitrum (SOBI.ST) with a buy rating and a price target of 530.00 kronor.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SOBI.ST

Track with the FINWIRES app suite

FolioX

Track SOBI.ST in your portfolio

WheelAI

Analyze SOBI.ST options with the wheel strategy

StockInsider

See market sentiment on SOBI.ST